Physician

Nathan Andrew Davis, MD

According to 2025 Medicare claims, Nathan Davis, MD (NPI: 1841443231) practices dermatology in the Corpus Christi, TX market, with the plurality of this provider's patient population coming from Nueces, TX. This provider's primary affiliated billing organization is SOUTH TEXAS DERMATOLOGY PLLC (NPI: 1356536494; TIN: 453829443) and primary practice location at 78411-2155.

Davis' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,628 traditional Medicare patients, billed 12,311 HCPCS/CPT codes, and received $515,363 in Medicare payments. The top billing code was 17110 (Destruction of skin growth, 1-14 growths). Part D data shows 2,493 prescription claims across 1,029 beneficiaries totaling $2,072,397 in drug costs, led by Skyrizi Pen (Risankizumab-Rzaa). Open Payments data shows 80 records totaling $2,136. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $269,824 to $2,072,397. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,584	10,515	$361,441
2016	1,699	13,387	$441,469
2017	1,891	14,433	$442,272
2018	1,872	20,292	$491,808
2019	1,828	15,960	$495,665
2020	1,758	14,962	$476,389
2021	1,855	14,142	$532,542
2022	1,780	13,983	$583,396
2023	1,600	14,335	$544,442
2024	1,628	12,311	$515,363

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	617	1,537	$269,824
2016	653	1,646	$460,774
2017	929	2,270	$1,049,778
2018	1,037	2,824	$1,491,145
2019	1,337	3,682	$1,660,219
2020	1,074	2,983	$1,834,632
2021	783	1,965	$1,671,253
2022	814	2,079	$1,667,716
2023	906	2,246	$1,771,370
2024	1,029	2,493	$2,072,397

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
17110	Destruction of skin growth, 1-14 growths	600	775	$78
11102	Biopsy of related skin growth, first growth	482	584	$59
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	1,282	1,865	$59
17000	Destruction of precancer skin growth, 1 growth	988	1,300	$36
17003	Destruction of precancer skin growth, 2-14 growths	807	5,545	$5

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Skyrizi Pen	Risankizumab-Rzaa	34	2,684	$715,780
Taltz Autoinjector	Ixekizumab	43	1,446	$340,731
Tremfya	Guselkumab	11	616	$146,711
Dupixent Pen	Dupilumab	26	686	$95,250
Humira Pen	Adalimumab	14	392	$94,978

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	80	$2,136	Galderma Laboratories, L.P.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Nathan Andrew Davis, MD?

Tedicare shows public-source Medicare data for Nathan Andrew Davis, MD (NPI 1841443231), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Nathan Andrew Davis, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Nathan Andrew Davis, MD?

Nathan Andrew Davis, MD is linked to SOUTH TEXAS DERMATOLOGY PLLC (billing NPI 1356536494) in the available physician profile data.

Does Nathan Andrew Davis, MD have Open Payments data?

Nathan Andrew Davis, MD has 80 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.